Location Princeton, New Jersey, United States Regions East Coast, Northeastern US Gender Male
LinkedIn View on LinkedIn X (Twitter) View on X
Over the past 18 years, Alex has had the opportunity to work for or consult for more than 60 public and private companies around the world. His experience spans a wide range of life science companies and sectors, from pre-seed + seed stage startups to multinational industry leaders. He has lived on 3 continents and conducted business in 20+
countries.
Alex is involved with several companies across the life science and tech space, in some as an active executive, others an advisor, or even a passive investor. At the top of the pyramid, Alex co-manages The Naissos Group, a family-owned holding company that launches, invests in, and provides advisory services to innovative ventures, with a focus on the life sciences. The portfolio has wholly-owned companies, stealth-mode ventures, and minority positions in outside investments. The lead operational business is TNG Creative, an award-winning, boutique [strategy + creative] consulting firm through which he supports several clients across North America, Europe, and Asia, from small early-stage startups to multinational companies and their blockbuster brands. .
Alex is also Chief Operating Officer at Oncolyze, an early stage oncology biotech developing a novel therapeutic OM-301 for the treatment of AML and other hematologic and solid cancers. Oncolyze is actively raising a Series A round to advance that asset into clinical development. Concurrently, Alex is an Advisor at several other early stage life science companies, including Enterin, Avanzarx, and Prolocor, and an Advisor to SoundTrac Ventures.
